相似文献
1
Effect of aztreonam on throat and stool flora of cancer patients.
Antimicrob Agents Chemother. 1984 Dec;26(6):941-3. doi: 10.1128/AAC.26.6.941.
2
Effect of broad-spectrum cephalosporins on the microbial flora of recipients.
J Infect Dis. 1983 Nov;148(5):892-7. doi: 10.1093/infdis/148.5.892.
3
Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Drugs. 1986 Feb;31(2):96-130. doi: 10.2165/00003495-198631020-00002.
4
Selective decontamination of the digestive tract with aztreonam: a study of 10 healthy volunteers.
J Infect Dis. 1984 Nov;150(5):636-42. doi: 10.1093/infdis/150.5.636.
5
Evaluation of the Activity of Aztreonam-Avibactam against 341 Recent Clinical Isolates of Anaerobes.
Microbiol Spectr. 2021 Dec 22;9(3):e0190821. doi: 10.1128/Spectrum.01908-21. Epub 2021 Dec 15.
6
[Effect of aztreonam on the fecal aerobic flora in children].
Pathol Biol (Paris). 1987 May;35(5):665-8.
7
Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient.
Rev Infect Dis. 1985 Nov-Dec;7 Suppl 4:S747-61. doi: 10.1093/clinids/7.supplement_4.s747.
8
[The study of drug resistance in aerobic and anaerobic bacterial flora to selected antibacterial drugs].
Med Dosw Mikrobiol. 1996;48(1-2):61-70.
9
Evaluation of the mandibular third molar pericoronitis flora and its susceptibility to different antibiotics prescribed in france.
J Clin Microbiol. 2003 Dec;41(12):5794-7. doi: 10.1128/JCM.41.12.5794-5797.2003.
10
Aztreonam in the prevention and treatment of infection in neutropenic cancer patients.
Am J Med. 1990 Mar 23;88(3C):24S-29S; discussion 38S-42S. doi: 10.1016/0002-9343(90)90084-q.
引用本文的文献
1
Host impairments in patients with neoplastic diseases.
Cancer Treat Res. 2014;161:1-41. doi: 10.1007/978-3-319-04220-6_1.
2
Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients.
N Engl J Med. 2000 Dec 28;343(26):1925-32. doi: 10.1056/NEJM200012283432604.
3
Evaluation of aztreonam in the treatment of severe bacterial infections.
Antimicrob Agents Chemother. 1985 Aug;28(2):222-6. doi: 10.1128/AAC.28.2.222.
4
Effect of broad-spectrum parenteral antibiotics on composition of intestinal microflora of humans.
Antimicrob Agents Chemother. 1987 Feb;31(2):202-6. doi: 10.1128/AAC.31.2.202.
5
Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Drugs. 1986 Feb;31(2):96-130. doi: 10.2165/00003495-198631020-00002.
6
Effect of imipenem-cilastatin therapy on fecal flora.
Antimicrob Agents Chemother. 1986 May;29(5):741-3. doi: 10.1128/AAC.29.5.741.
7
Modulation of the intestinal flora of mice by treatment with aztreonam and tigemonam.
Antimicrob Agents Chemother. 1991 May;35(5):983-5. doi: 10.1128/AAC.35.5.983.
本文引用的文献
1
Comparative in vitro study of SQ26,776.
Antimicrob Agents Chemother. 1982 Feb;21(2):294-8. doi: 10.1128/AAC.21.2.294.
2
Patterns of oropharyngeal and fecal flora in patients with acute leukemia.
J Infect Dis. 1981 Jul;144(1):10-8. doi: 10.1093/infdis/144.1.10.
3
Effect of cefoperazone on faecal flora.
J Antimicrob Chemother. 1983 Aug;12(2):163-7. doi: 10.1093/jac/12.2.163.
4
Effect of broad-spectrum cephalosporins on the microbial flora of recipients.
J Infect Dis. 1983 Nov;148(5):892-7. doi: 10.1093/infdis/148.5.892.
5
Semiquantitative oropharyngeal culture technique.
Appl Microbiol. 1970 Aug;20(2):218-23. doi: 10.1128/am.20.2.218-223.1970.
6
Effect of prophylactic measures on the microbial flora of patients in protected environment units.
Medicine (Baltimore). 1974 May;53(3):209-28. doi: 10.1097/00005792-197405000-00004.
Zotero 插件